• Structural Basis for Cooperative STING Activation by PI4P an

  2026-05-29

  This study reveals that the Golgi lipid PI4P and the small molecule agonist GNE-6468 synergistically activate STING by inducing transmembrane helix rearrangement, as determined by cryo-EM. These mechanistic insights clarify the molecular basis for STING activation and highlight novel strategies for immunotherapy and anti-cancer drug discovery.

• IWP-L6 (SKU B2305): Reliable Porcupine Inhibition for Wnt St

  2026-05-29

  This article empowers biomedical researchers and lab technicians to address real-world challenges in Wnt signaling and cell-based assays using IWP-L6 (SKU B2305), a highly potent Porcupine inhibitor. Drawing on recent literature and validated protocols, the piece guides users through practical scenarios—highlighting reproducibility, sensitivity, and workflow efficiency. Whether troubleshooting inconsistent Wnt pathway data or selecting a reliable vendor, readers will find evidence-backed strategies to optimize experimental outcomes with IWP-L6.

• ML385 and Strategic NRF2 Inhibition: Redefining Translationa

  2026-05-28

  This thought-leadership article explores the mechanistic underpinnings and translational potential of ML385, a selective NRF2 inhibitor, in overcoming therapeutic resistance and modulating redox pathways. By synthesizing insights from recent literature—including evidence from alcoholic liver disease and non-small cell lung cancer models—we provide actionable guidance for translational scientists, highlight protocol best practices, and frame the evolving competitive landscape for NRF2 pathway inhibitors. The discussion bridges foundational cancer biology, emerging applications in ferroptosis and inflammation, and workflow innovation, establishing a new strategic paradigm for biomedical researchers.

• Capsaicin-Induced Autophagy Preserves BMSC Function in Stres

  2026-05-28

  This article explores how capsaicin activates autophagy in bone marrow stromal cells (BMSCs) via TRPV1-mediated calcium influx and PI3K/AKT/mTOR pathway modulation to protect cell function under oxidative stress. These findings illuminate therapeutic strategies for osteoporosis and guide experimental approaches to studying cell survival and differentiation.

• GPR35-KLF5 Axis Decodes Colonic Injury for Epithelial Repair

  2026-05-27

  This study uncovers a tryptophan metabolism-driven molecular circuit in which GPR35 detects mucosal damage and activates KLF5-mediated repair pathways in intestinal epithelial cells. The findings offer mechanistic insight into how epithelial repair is programmed after injury and highlight potential therapeutic targets for ulcerative colitis.

• Dimethyloxalylglycine (DMOG): Technical Use and Protocol Gui

  2026-05-27

  Dimethyloxalylglycine (DMOG) provides a reliable approach for stabilizing hypoxia-inducible factors in experimental models, supporting research in hypoxia signaling and inflammation. It is not intended for diagnostic or clinical use and requires precise protocol adherence for reproducible results.

• Alternariol: Advanced Mechanisms and Hepatotoxicity Insights

  2026-05-26

  Explore the multifaceted role of Alternariol (AOH) in mycotoxin research, with a focus on its advanced mechanisms of action, cytochrome P450 metabolism, and recent breakthroughs in hepatotoxicity and fibrosis. This article delivers new perspectives for assay optimization and risk assessment.

• KN-62: Precision CaMKII Inhibition for Metabolic & Cell Cycl

  2026-05-26

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, stands out as a highly selective CaMKII inhibitor enabling precise dissection of calcium signaling in metabolic and cell cycle studies. This guide delivers actionable workflows, troubleshooting insights, and practical innovations, empowering researchers to maximize data quality and reproducibility in CaMKII-driven pathways.

• ATRA Reverses Cisplatin-Induced PARP Inhibitor Resistance in

  2026-05-25

  This study demonstrates that all-trans retinoic acid (ATRA) can overcome cisplatin-induced resistance to PARP inhibition in epithelial ovarian cancer (EOC) models. By targeting NAD+-dependent pathways, ATRA restores sensitivity to PARP inhibitors like Niraparib, offering a promising strategy to enhance maintenance therapy in recurrent or resistant EOC.

• Applied Workflows with (-)-Blebbistatin: Precision in NM II

  2026-05-25

  (-)-Blebbistatin enables reproducible, selective inhibition of non-muscle myosin II, powering advanced cytoskeletal, cardiac, and cell migration studies. This article demystifies protocol optimizations, highlights troubleshooting strategies, and translates cutting-edge research into actionable experimental workflows.

• UBR1/UBR2 as ER Stress Sensors: Insights into Proteasome Reg

  2026-05-24

  This article examines the pivotal discovery that N-recognin E3 ligases UBR1 and UBR2 serve as central ER stress sensors in mammalian cells, as reported by Le et al. The study provides mechanistic insight into ER-associated degradation and protein quality control, with implications for ubiquitin-proteasome pathway research and disease modeling.

• Early Life Adversity Disrupts Defensive Behaviors via Oxytoc

  2026-05-23

  This study reveals that early life adversity (ELA), modeled through social deprivation in mice, impairs visually triggered innate defensive behaviors by downregulating oxytocin signaling in the superior colliculus. The findings clarify a mechanistic link between early environmental stress and long-term deficits in threat detection, informing future research on neurodevelopmental resilience and intervention strategies.

• Epalrestat: Aldose Reductase Inhibitor for Advanced Disease

  2026-05-22

  Epalrestat, a high-purity aldose reductase inhibitor, enables precise modulation of oxidative stress pathways in both diabetic neuropathy and neurodegeneration research. Unique dual mechanisms—including direct KEAP1/Nrf2 pathway activation—set it apart for constructing robust in vitro and in vivo models.

• Sumatriptan Succinate: Bridging Mechanism, Translation, and

  2026-05-22

  Explore how Sumatriptan Succinate, a potent 5-HT1 receptor agonist, is shaping migraine and inflammation research. This article provides mechanistic clarity, workflow guidance, and translational strategy for researchers, with direct citation of pediatric ED evidence and APExBIO's validated compound.

• Bcl-xL Drives Quiescent Survival in Nutrient-Deprived Pancre

  2026-05-21

  This study demonstrates how Bcl-xL enforces a slow-cycling, chemoresistant state in pancreatic cancer cells exposed to nutrient and oxygen deprivation. By integrating transcriptomic, metabolomic, and CRISPR screening data, the authors reveal the essential adaptation mechanisms of quiescent cancer cells and highlight new therapeutic strategies targeting both proliferative and dormant tumor populations.

16575 records 1/1105 page Next 12345 下5页 Last page